[Federal Register Volume 76, Number 22 (Wednesday, February 2, 2011)]
[Notices]
[Pages 5829-5830]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2011-2295]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated August 3, 2010, and published in the Federal 
Register on September 1, 2010, 75 FR 53719, Cambridge Isotope Lab, 50 
Frontage Road, Andover, Massachusetts 01810, made application by 
renewal to the Drug Enforcement Administration (DEA) to be registered 
as a bulk manufacturer of Morphine (9300), a basic class of controlled 
substance listed in schedule II.
    The company plans to utilize small quantities of the listed 
controlled substance in the preparation of analytical standards.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and determined that the registration of 
Cambridge Isotope Lab to manufacture the listed basic class of 
controlled substance is consistent with the public interest at this 
time. DEA has

[[Page 5830]]

investigated Cambridge Isotope Lab to ensure that the company's 
registration is consistent with the public interest. The investigation 
has included inspection and testing of the company's physical security 
systems, verification of the company's compliance with state and local 
laws, and a review of the company's background and history. Therefore, 
pursuant to 21 U.S.C. 823(a), and in accordance with 21 CFR 1301.33, 
the above named company is granted registration as a bulk manufacturer 
of the basic class of controlled substance listed.

    Dated: January 18, 2011.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2011-2295 Filed 2-1-11; 8:45 am]
BILLING CODE 4410-09-P